Hospitals Zimmer Biomet Announces FDA Approval of Expanded 26-week Efficacy Claim for Gel-One® Cross-Linked Hyaluronate for Treatment of Pain Associated with Knee Osteoarthritis byJosh SandbergFebruary 2, 2017
Biologics Interventional Orthopedics Foundation Shines Light on False Claims about Stem Cell Products byJosh SandbergDecember 16, 2015
Financial Workers’ compensation policies show variation in costs, claims byJosh SandbergDecember 3, 2015
Financial Top Stories Hip implant maker claims surgical funder inflated patients’ bills byJosh SandbergSeptember 28, 2015
